Abstract
Alendronate is an antiresorptive therapy for osteoporosis and results in a decrease in bone turnover. To choose the optimal measurement for monitoring this therapy, the size of the change needs to be compared with the variability of the measurement. We studied 26 women with postmenopausal osteoporosis (bone mineral density [BMD] T score
Cite
CITATION STYLE
APA
Machado, A. B. D. C., Hannon, R., & Eastell, R. (1999). Monitoring alendronate therapy for osteoporosis. Journal of Bone and Mineral Research, 14(4), 602–608. https://doi.org/10.1359/jbmr.1999.14.4.602
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free